MOTS-c 10mg
Price range: 31,99 € through 63,99 €
Frequently bought together
MOTS-c Europe Mitochondrial ORF of the 12S rRNA Type-c · mtDNA-Encoded Peptide
MOTS-c Europe is supplied by Baltic Peptides as a lyophilised research peptide at ≥99% analytical purity, verified per batch by independent HPLC and mass spectrometry. MOTS-c is a 16-residue peptide (Met-Arg-Trp-Gln-Glu-Met-Gly-Tyr-Ile-Phe-Tyr-Pro-Arg-Lys-Leu-Arg) encoded by a short open reading frame inside the mitochondrial 12S rRNA gene.
Described in 2015 by Lee and colleagues, MOTS-c was one of the first peptides shown to be encoded by mitochondrial DNA and to act as a signalling molecule elsewhere in the body. In mouse studies, it inhibits the folate cycle, raises AICAR and activates AMPK, improving insulin sensitivity and protecting against diet-induced obesity. Under stress, it can also move into the nucleus and influence gene expression.
Supplied exclusively for in vitro and preclinical research by qualified investigators and licensed research institutions.
Third-Party Verified · COA Available · EU Dispatch
Analytical Purity
HPLC · Mass Spec Verified
Key Features
Researchers choosing MOTS-c Europe from Baltic Peptides receive a ≥99% HPLC-verified, independently tested mitochondrial-derived peptide dispatched from within the EU.
-
Purity — ≥99% by HPLC analysis
-
Form — Lyophilised powder, single vials
-
Storage (long-term) — −20 °C, desiccated, protected from light
-
Storage (short-term) — 2–8 °C, up to 4 weeks
-
Solubility — Sterile water, PBS or bacteriostatic water
-
Classification — Research Use Only (RUO)
-
Testing — Independent third-party batch verification
-
Documentation — Certificate of Analysis per batch
Scientific Overview — MOTS-c Europe
Compound Background
A Peptide Encoded by Mitochondria
Mitochondria keep a small genome of their own, long thought to encode only 13 proteins plus rRNAs and tRNAs. MOTS-c was found by searching for short open reading frames hidden inside the mitochondrial rRNA genes, following the earlier discovery of humanin in the 16S rRNA gene. Lee et al. (Cell Metabolism, 2015) showed MOTS-c circulates in plasma and acts on skeletal muscle as a metabolic regulator. Because the mitochondrial genetic code differs from the standard code, where it is translated is still discussed; evidence suggests translation in the cytoplasm.
Mechanistically, MOTS-c inhibits the folate–methionine cycle and de novo purine synthesis, causing the intermediate AICAR to accumulate and activate AMPK. In mice it improved glucose handling, prevented diet-induced weight gain and improved physical performance in older animals. Circulating levels fall with age in some studies and rise with exercise.
MOTS-c vs Humanin
| Parameter | MOTS-c | Humanin |
|---|---|---|
| Encoded in | 12S rRNA gene (mtDNA) | 16S rRNA gene (mtDNA) |
| Length | 16 aa | 24 aa |
| Main research focus | Metabolism, AMPK, insulin sensitivity | Cell survival, neuroprotection |
| Key mechanism | Folate cycle → AICAR → AMPK | Anti-apoptotic receptor signalling |
Primary Research Domains
Signalling Pathway — Research Context
MOTS-c
Folate Cycle / Purine Synthesis
AICAR
AMPK Activation
↑ Glucose Uptake · Insulin Sensitivity
Technical Specifications — MOTS-c Europe
| Parameter | Specification |
|---|---|
| Compound Name | MOTS-c (Mitochondrial ORF of the 12S rRNA type-c) |
| Compound Class | Mitochondrial-derived peptide (MDP) |
| Sequence | H-MRWQEMGYIFYPRKLR-OH |
| Molecular Formula | C101H152N28O22S2 |
| Molecular Weight | 2174.6 g/mol |
| CAS Number | 1627580-64-6 |
| Purity | ≥99% (HPLC verified per batch) |
| Form / Appearance | White to off-white lyophilised powder |
| Solubility | Sterile water, PBS or bacteriostatic water (≥1 mg/mL) |
| Oxidation-Sensitive Residues | Met1, Trp3, Met6 |
| Long-Term Storage | −20 °C, desiccated, protected from light |
| Short-Term Storage | 2–8 °C, sealed vial, up to 4 weeks |
| Reconstituted Stability | Up to 14 days at 2–8 °C; avoid freeze-thaw cycling |
| Research Classification | Research Use Only (RUO) |
| Supplier | Baltic Peptides — EU dispatch from Lithuania |
MOTS-c Europe — Lab Testing & Quality Assurance
Each batch is independently tested before release and published per lot on our COA page.
HPLC Purity Analysis
Reverse-phase HPLC confirms ≥99% purity with quantified impurity profiling.
Mass Spectrometry
ESI-MS confirms the expected 2174.6 Da mass and screens for +16 Da methionine-sulfoxide and tryptophan-oxidation products.
Certificate of Analysis
A batch-specific COA documents purity, identity, lot number, testing dates and method references.
Third-Party Verification
Analytical data is generated by independent external laboratories for auditable, conflict-free documentation.
Storage & Handling — MOTS-c Europe
With two methionines and a tryptophan, MOTS-c is more oxidation-prone than most short peptides. Keep it cold, dry and away from light, and limit air exposure after opening. See our cold-chain storage guide.
Lyophilised (Unopened)
−20 °C, desiccated. Stable for 24 months from manufacture. Protect from light and moisture.
Short-Term (Unopened)
2–8 °C for up to 4 weeks in the sealed vial.
Reconstituted Solution
2–8 °C, closed and light-protected. Use within 14 days. Avoid freeze-thaw cycling.
Reconstitution
Add solvent slowly down the vial wall and swirl gently — do not vortex. Method as in our peptide reconstitution guide.
Related Research Reading
Further reading from the Baltic Peptides Research Library:
Research Use Only — Important Notice
All products supplied by Baltic Peptides are designated exclusively for in vitro research, preclinical investigation, and laboratory study by qualified professionals operating within appropriately licensed or regulated research environments.
MOTS-c Europe is not approved for human or veterinary use by any medicines regulator and is not intended for self-administration, clinical application, or any use outside controlled scientific research.
By completing a purchase, the buyer confirms their status as a qualified researcher and acknowledges the research-use-only classification of this compound. Baltic Peptides assumes no liability for any use beyond its stated research designation.
Frequently Asked Questions — MOTS-c Europe
What is MOTS-c?
MOTSc EU is a 16-residue peptide (MRWQEMGYIFYPRKLR) encoded in the mitochondrial 12S rRNA gene. Its formula is C101H152N28O22S2, molecular weight 2174.6 g/mol and CAS number 1627580-64-6. Baltic Peptides supplies MOTS-c in Europe at ≥99% purity.
Why is MOTS-c’s mitochondrial origin significant?
It shows that the mitochondrial genome encodes signalling peptides as well as respiratory-chain proteins, giving mitochondria a direct way to communicate with the rest of the cell and body.
How does MOTS-c activate AMPK?
It inhibits the folate cycle and purine synthesis, which causes the intermediate AICAR to build up. AICAR mimics AMP and activates AMPK.
How should MOTS-c Europe be stored to prevent oxidation?
Store lyophilised at −20 °C, dry and light-protected. After reconstitution, keep at 2–8 °C, minimise headspace air and use within 14 days. Methionine oxidation shows up as +16 Da peaks by mass spectrometry.
How does MOTS-c relate to humanin?
Both are mitochondrial-derived peptides encoded within rRNA genes — humanin in 16S, MOTS-c in 12S. Humanin is studied mainly for cell survival and neuroprotection; MOTS-c mainly for metabolism.
Is a Certificate of Analysis available for MOTS-c Europe?
Yes. Every MOTSc Europe lot comes with a batch-specific COA documenting purity, identity, lot number and testing dates, published on the Baltic Peptides COA page.
What are the shipping conditions for MOTS-c Europe?
If you buy MOTSc Europe, it ships from Lithuania, giving shorter transit times and no non-EU customs exposure for European researchers. Orders are packed with temperature- and light-protective materials and fully tracked. See our shipping page.





